Citius Pharmaceuticals Inc (NAS:CTXR)
$ 0.4115 0.0293 (7.67%) Market Cap: 74.37 Mil Enterprise Value: 56.78 Mil PE Ratio: 0 PB Ratio: 0.87 GF Score: 33/100

Citius Pharmaceuticals Inc at Sidoti & Company January Micro-Cap Virtual Conference Transcript

Jan 18, 2023 / 03:45PM GMT
Release Date Price: $1.3 (+15.04%)
Stephane Guillaume
Sidoti & Company, LLC - Analyst

Good morning, everyone, and welcome to the Sidoti January 2023 Micro-Cap Conference. My name is [Stephane Guillaume]. Today, I'm joined by Leonard Mazur, CEO and Chairman of Citius Pharmaceutical, ticker CTXR. We will have a total of 30 minutes, so with no further delay, I will turn it over to you.

Leonard Mazur
Citius Pharmaceuticals, Inc. - Co-Founder, CEO & Chairman

All right, Stephane. Thank you very much for the introduction. And also, thank you to everybody that's going to be watching this presentation. I appreciate all of you taking the time to tune in and hear some facts about the company. Before we get started, since I'll be making forward-looking statements, I just want to add that all of you should consult the SEC website, sec.gov, plus Citius Pharma website as well, CTXR, for all the additional information that you would need in order to make an informed decision about our company.

So let me start with some investment highlights for you. We have a diversified pipeline. We started

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot